Differences between effects of psychological versus pharmacological treatments on functional and morphological brain alterations in anxiety disorders and major depressive disorder: A systematic review

Neuroscience and Biobehavioral Reviews

Volumn 36, Issue 1, 2012, Pages 626-644

  Quidé, Yann ^a,b,c   Witteveen, Anke B ^a   El Hage, Wissam ^b,c,d   Veltman, Dick J ^a,e   Olff, Miranda ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITÉ DE TOURS   (France)

^c CHRU de Tours   (France)

^d UNIVERSITY HOSPITAL OF TOURS   (France)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anxiety disorders; Brain imaging; CBT; EMDR; Functional neuroimaging; IPT; Major depressive disorder; Pharmacotherapy; Psychotherapy; SSRI; Structural neuroimaging; Treatment

Indexed keywords

AMESERGIDE; CITALOPRAM; CYSTEINE ETHYL ESTER TC 99M; ESCITALOPRAM; FLUORODEOXYGLUCOSE F 18; FLUOXETINE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; MOCLOBEMIDE; NEFAZODONE; OXYGEN 15; PAROXETINE; PHENYTOIN; RILUZOLE; SERTRALINE; TIAGABINE; TRAZODONE; VENLAFAXINE;

AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; ANXIETY DISORDER; BEHAVIOR THERAPY; BRAIN SIZE; COGNITION; COGNITIVE THERAPY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENERALIZED ANXIETY DISORDER; HIPPOCAMPUS; HUMAN; LIMBIC CORTEX; MAJOR DEPRESSION; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSIVE COMPULSIVE DISORDER; PANIC; PHOBIA; POSITRON EMISSION TOMOGRAPHY; POSTTRAUMATIC STRESS DISORDER; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOCIAL PHOBIA; SYSTEMATIC REVIEW; TASK PERFORMANCE; VOXEL BASED MORPHOMETRY;

ANXIETY DISORDERS; BRAIN; DEPRESSIVE DISORDER, MAJOR; HUMANS; PSYCHOTHERAPY; PSYCHOTROPIC DRUGS;

EID: 82855161301     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2011.09.004     Document Type: Review

References (165)

1. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 1986, 9:357-381.
2. Aouizerate B., Guehl D., Cuny E., Rougier A., Bioulac B., Tignol J., Burbaud P. Pathophysiology of obsessive-compulsive disorder: a necessary link between phenomenology, neuropsychology, imagery and physiology. Prog. Neurobiol. 2004, 72:195-221.
3. APA. Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Association, Washington, DC. 4th ed.
4. Apfel B.A., Ross J., Hlavin J., Meyerhoff D.J., Metzler T.J., Marmar C.R., Weiner M.W., Schuff N., Neylan T.C. Hippocampal volume differences in gulf war veterans with current versus lifetime posttraumatic stress disorder symptoms. Biol. Psychiatry 2011, 69:541-548.
5. Atmaca M., Yildirim B.H., Ozdemir B.H., Aydin B.A., Tezcan A.E., Ozler A.S. Volumetric MRI assessment of brain regions in patients with refractory obsessive-compulsive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2006, 30:1051-1057.
6. Atmaca M., Yildirim H., Ozdemir H., Tezcan E., Poyraz A.K. Volumetric MRI study of key brain regions implicated in obsessive-compulsive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31:46-52.
7. Aupperle R.L., Hale L.R., Chambers R.J., Cain S.E., Barth F.X., Sharp S.C., Denney D.R., Savage C.R. An fMRI study examining effects of acute d-cycloserine during symptom provocation in spider phobia. CNS Spectrom. 2009, 14:556-571.
8. Baddeley A.D. Human Memory: Theory and Practice 1998, Allyn & Bacon.
9. Baxter L.R., Schwartz J.M., Bergman K.S., Szuba M.P., Guze B.H., Mazziotta J.C., Alazraki A., Selin C.E., Ferng H.K., Munford P., et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch. Gen. Psychiatry 1992, 49:681-689.
10. Baxter L.R., Thompson J.M., Schwartz J.M., Guze B.H., Phelps M.E., Mazziotta J.C., Selin C.E., Moss L. Trazodone treatment response in obsessive-compulsive disorder-correlated with shifts in glucose metabolism in the caudate nuclei. Psychopathology 1987, 20(Suppl. 1):114-122.
11. Bossini L., Fagiolini A., Castrogiovanni P. Neuroanatomical changes after eye movement desensitization and reprocessing (EMDR) treatment in posttraumatic stress disorder. J. Neuropsychiatry Clin. Neurosci. 2007, 19.
12. Bossini L., Tavanti M., Lombardelli A., Calossi S., Polizzotto N.R., Galli R., Vatti G., Pieraccini F., Castrogiovanni P. Changes in hippocampal volume in patients with post-traumatic stress disorder after sertraline treatment. J. Clin. Psychopharmacol. 2007, 27:233-235.
13. Botteron K.N., Raichle M.E., Drevets W.C., Heath A.C., Todd R.D. Volumetric reduction in left subgenual prefrontal cortex in early onset depression. Biol. Psychiatry 2002, 51:342-344.
14. Bremner J.D., Mletzko T., Welter S., Quinn S., Williams C., Brummer M., Siddiq S., Reed L., Heim C.M., Nemeroff C.B. Effects of phenytoin on memory, cognition and brain structure in post-traumatic stress disorder: a pilot study. J. Psychopharmacol. 2005, 19:159-165.
15. Bremner J.D., Narayan M., Staib L.H., Southwick S.M., McGlashan T., Charney D.S. Neural correlates of memories of childhood sexual abuse in women with and without posttraumatic stress disorder. Am. J. Psychiatry 1999, 156:1787-1795.
16. Bremner J.D., Vythilingam M., Vermetten E., Southwick S.M., McGlashan T., Nazeer A., Khan S., Vaccarino L.V., Soufer R., Garg P.K., Ng C.K., Staib L.H., Duncan J.S., Charney D.S. MRI and PET study of deficits in hippocampal structure and function in women with childhood sexual abuse and posttraumatic stress disorder. Am. J. Psychiatry 2003, 160:924-932.
17. Bremner J.D., Vythilingam M., Vermetten E., Southwick S.M., McGlashan T., Staib L.H., Soufer R., Charney D.S. Neural correlates of declarative memory for emotionally valenced words in women with posttraumatic stress disorder related to early childhood sexual abuse. Biol. Psychiatry 2003, 53:879-889.
18. Brewin C.R. What is it that a neurobiological model of PTSD must explain?. Prog. Brain Res. 2008, 167:217-228.
19. Britton J.C., Gold A.L., Feczko E.J., Rauch S.L., Williams D., Wright C.I. d-Cycloserine inhibits amygdala responses during repeated presentations of faces. CNS Spectr. 2007, 12:600-605.
20. Brockmann H., Zobel A., Joe A., Biermann K., Scheef L., Schuhmacher A., von Widdern O., Metten M., Biersack H.J., Maier W., Boecker H. The value of HMPAO SPECT in predicting treatment response to citalopram in patients with major depression. Psychiatry Res. 2009, 173:107-112.
21. Brody A.L., Saxena S., Stoessel P., Gillies L.A., Fairbanks L.A., Alborzian S., Phelps M.E., Huang S.C., Wu H.M., Ho M.L., Ho M.K., Au S.C., Maidment K., Baxter L.R. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch. Gen. Psychiatry 2001, 58:631-640.
22. Brown T.A., Campbell L.A., Lehman C.L., Grisham J.R., Mancill R.B. Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. J. Abnorm. Psychol. 2001, 110:585-599.
23. Bryant R.A., Felmingham K., Whitford T.J., Kemp A., Hughes G., Peduto A., Williams L.M. Rostral anterior cingulate volume predicts treatment response to cognitive-behavioural therapy for posttraumatic stress disorder. J. Psychiatry Neurosci. 2008, 33:142-146.
24. Bryant R.A., Felmingham K., Kemp A., Das P., Hughes G., Peduto A., Williams L. Amygdala and ventral anterior cingulate activation predicts treatment response to cognitive behaviour therapy for post-traumatic stress disorder. Psychol. Med. 2008, 38:555-561.
25. Bush G., Luu P., Posner M.I. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn. Sci. 2000, 4:215-222.
26. Caetano S.C., Kaur S., Brambilla P., Nicoletti M., Hatch J.P., Sassi R.B., Mallinger A.G., Keshavan M.S., Kupfer D.J., Frank E., Soares J.C. Smaller cingulate volumes in unipolar depressed patients. Biol. Psychiatry 2006, 59:702-706.
27. Carey P.D., Warwick J., Niehaus D.J., van der Linden G., van Heerden B.B., Harvey B.H., Seedat S., Stein D.J. Single photon emission computed tomography (SPECT) of anxiety disorders before and after treatment with citalopram. BMC Psychiatry 2004, 4:30.
28. Cassimjee N., Fouche J.P., Burnett M., Lochner C., Warwick J., Dupont P., Stein D.J., Cloete K.J., Carey P.D. Changes in regional brain volumes in social anxiety disorder following 12 weeks of treatment with escitalopram. Metab. Brain Dis. 2010, 25:369-374.
29. Coffey C.E., Wilkinson W.E., Weiner R.D., Parashos I.A., Djang W.T., Webb M.C., Figiel G.S., Spritzer C.E. Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study. Arch. Gen. Psychiatry 1993, 50:7-16.
30. Corbo V., Clement M.H., Armony J.L., Pruessner J.C., Brunet A. Size versus shape differences: contrasting voxel-based and volumetric analyses of the anterior cingulate cortex in individuals with acute posttraumatic stress disorder. Biol. Psychiatry 2005, 58:119-124.
31. Craig A.D. A new view of pain as a homeostatic emotion. Trends Neurosci. 2003, 26:303-307.
32. Critchley H.D., Mathias C.J., Dolan R.J. Fear conditioning in humans: the influence of awareness and autonomic arousal on functional neuroanatomy. Neuron 2002, 33:653-663.
33. Davidson R.J. Affective neuroscience and psychophysiology: toward a synthesis. Psychophysiology 2003, 40:655-665.
34. Davis M., Myers K.M., Ressler K.J., Rothbaum B.O. Facilitation of extinction of conditionned fear by d-cycloserine: implications for psychotherapy. Curr. Dir. Psychol. Med. 2005, 14:214-219.
35. De Bellis M.D., Casey B.J., Dahl R.E., Birmaher B., Williamson D.E., Thomas K.M., Axelson D.A., Frustaci K., Boring A.M., Hall J., Ryan N.D. A pilot study of amygdala volumes in pediatric generalized anxiety disorder. Biol. Psychiatry 2000, 48:51-57.
36. De Bellis M.D., Hall J., Boring A.M., Frustaci K., Moritz G. A pilot longitudinal study of hippocampal volumes in pediatric maltreatment-related posttraumatic stress disorder. Biol. Psychiatry 2001, 50:305-309.
37. DeRubeis R.J., Siegle G.J., Hollon S.D. Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms. Nat. Rev. Neurosci. 2008, 9:788-796.
38. Dichter G.S., Felder J.N., Petty C., Bizzell J., Ernst M., Smoski M.J. The effects of psychotherapy on neural responses to rewards in major depression. Biol. Psychiatry 2009, 66:886-897.
39. Drevets W.C. Neuroimaging studies of mood disorders. Biol. Psychiatry 2000, 48:813-829.
40. Drevets W.C., Bogers W., Raichle M.E. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur. Neuropsychopharmacol. 2002, 12:527-544.
41. Engel K., Bandelow B., Gruber O., Wedekind D. Neuroimaging in anxiety disorders. J. Neural Transm. 2009, 116:703-716.
42. Evans K.C., Simon N.M., Dougherty D.D., Hoge E.A., Worthington J.J., Chow C., Kaufman R.E., Gold A.L., Fischman A.J., Pollack M.H., Rauch S.L. A PET study of tiagabine treatment implicates ventral medial prefrontal cortex in generalized social anxiety disorder. Neuropsychopharmacology 2009, 34:390-398.
43. Fales C.L., Barch D.M., Rundle M.M., Mintun M.A., Mathews J., Snyder A.Z., Sheline Y.I. Antidepressant treatment normalizes hypoactivity in dorsolateral prefrontal cortex during emotional interference processing in major depression. J. Affect. Disord. 2009, 112:206-211.
44. Farrow T.F., Hunter M.D., Wilkinson I.D., Gouneea C., Fawbert D., Smith R., Lee K.H., Mason S., Spence S.A., Woodruff P.W. Quantifiable change in functional brain response to empathic and forgivability judgments with resolution of posttraumatic stress disorder. Psychiatry Res. 2005, 140:45-53.
45. Felmingham K., Kemp A., Williams L., Das P., Hughes G., Peduto A., Bryant R. Changes in anterior cingulate and amygdala after cognitive behavior therapy of posttraumatic stress disorder. Psychol. Sci. 2007, 18:127-129.
46. Fitzgerald P.B., Laird A.R., Maller J., Daskalakis Z.J. A meta-analytic study of changes in brain activation in depression. Hum. Brain Mapp. 2008, 29:683-695.
47. Fredrikson M., Wik G., Greitz T., Eriksson L., Stone-Elander S., Ericson K., Sedvall G. Regional cerebral blood flow during experimental phobic fear. Psychophysiology 1993, 30:126-130.
48. Freeman T.W., Cardwell D., Karson C.N., Komoroski R.A. In vivo proton magnetic resonance spectroscopy of the medial temporal lobes of subjects with combat-related posttraumatic stress disorder. Magn. Reson. Med. 1998, 40:66-71.
49. Frewen P.A., Dozois D.J., Lanius R.A. Neuroimaging studies of psychological interventions for mood and anxiety disorders: empirical and methodological review. Clin. Psychol. Rev. 2008, 28:228-246.
50. Fujihira T., Kanematsu S., Umino A., Yamamoto N., Nishikawa T. Selective increase in the extracellular d-serine contents by d-cycloserine in the rat medial frontal cortex. Neurochem. Int. 2007, 51:233-236.
51. Furmark T., Tillfors M., Marteinsdottir I., Fischer H., Pissiota A., Langstrom B., Fredrikson M. Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. Arch. Gen. Psychiatry 2002, 59:425-433.
52. Gilbert A.R., Moore G.J., Keshavan M.S., Paulson L.A., Narula V., Mac Master F.P., Stewart C.M., Rosenberg D.R. Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine. Arch. Gen. Psychiatry 2000, 57:449-456.
53. Gilbertson M.W., Shenton M.E., Ciszewski A., Kasai K., Lasko N.B., Orr S.P., Pitman R.K. Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma. Nat. Neurosci. 2002, 5:1242-1247.
54. Goldapple K., Segal Z., Garson C., Lau M., Bieling P., Kennedy S., Mayberg H. Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch. Gen. Psychiatry 2004, 61:34-41.
55. Goossens L., Schruers K., Peeters R., Griez E., Sunaert S. Visual presentation of phobic stimuli: amygdala activation via an extrageniculostriate pathway?. Psychiatry Res. 2007, 155:113-120.
56. Gorman J.M., Kent J.M., Sullivan G.M., Coplan J.D. Neuroanatomical hypothesis of panic disorder, revised. Am. J. Psychiatry 2000, 157:493-505.
57. Hansen E.S., Hasselbalch S., Law I., Bolwig T.G. The caudate nucleus in obsessive-compulsive disorder. Reduced metabolism following treatment with paroxetine: a PET study. Int. J. Neuropsychopharmacol. 2002, 5:1-10.
58. Hastings R.S., Parsey R.V., Oquendo M.A., Arango V., Mann J.J. Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression. Neuropsychopharmacology 2004, 29:952-959.
59. Hendler T., Goshen E., Tzila Zwas S., Sasson Y., Gal G., Zohar J. Brain reactivity to specific symptom provocation indicates prospective therapeutic outcome in OCD. Psychiatry Res. 2003, 124:87-103.
60. Herry C., Ferraguti F., Singewald N., Letzkus J.J., Ehrlich I., Luthi A. Neuronal circuits of fear extinction. Eur. J. Neurosci. 2010, 31:599-612.
61. Hoehn-Saric R., Schlund M.W., Wong S.H. Effects of citalopram on worry and brain activation in patients with generalized anxiety disorder. Psychiatry Res. 2004, 131:11-21.
62. Huey E.D., Zahn R., Krueger F., Moll J., Kapogiannis D., Wassermann E.M., Grafman J. A psychological and neuroanatomical model of obsessive-compulsive disorder. J. Neuropsychiatry Clin. Neurosci. 2008, 20:390-408.
63. Jang J.H., Kwon J.S., Jang D.P., Moon W.J., Lee J.M., Ha T.H., Chung E.C., Kim I.Y., Kim S.I. A proton MRSI study of brain N-acetylaspartate level after 12 weeks of citalopram treatment in drug-naive patients with obsessive-compulsive disorder. Am. J. Psychiatry 2006, 163:1202-1207.
64. Jetty P.V., Charney D.S., Goddard A.W. Neurobiology of generalized anxiety disorder. Psychiatr. Clin. N. Am. 2001, 24:75-97.
65. Johanson A., Gustafson L., Passant U., Risberg J., Smith G., Warkentin S., Tucker D. Brain function in spider phobia. Psychiatry Res. 1998, 84:101-111.
66. Kasai K., Yamasue H., Gilbertson M.W., Shenton M.E., Rauch S.L., Pitman R.K. Evidence for acquired pregenual anterior cingulate gray matter loss from a twin study of combat-related posttraumatic stress disorder. Biol. Psychiatry 2008, 63:550-556.
67. Kennedy S.H., Evans K.R., Kruger S., Mayberg H.S., Meyer J.H., McCann S., Arifuzzman A.I., Houle S., Vaccarino F.J. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am. J. Psychiatry 2001, 158:899-905.
68. Kennedy S.H., Konarski J.Z., Segal Z.V., Lau M.A., Bieling P.J., McIntyre R.S., Mayberg H.S. Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. Am. J. Psychiatry 2007, 164:778-788.
69. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 2005, 62:593-602.
70. Kilts C.D., Kelsey J.E., Knight B., Ely T.D., Bowman F.D., Gross R.E., Selvig A., Gordon A., Newport D.J., Nemeroff C.B. The neural correlates of social anxiety disorder and response to pharmacotherapy. Neuropsychopharmacology 2006, 31:2243-2253.
71. Konarski J.Z., McIntyre R.S., Kennedy S.H., Rafi-Tari S., Soczynska J.K., Ketter T.A. Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder. Bipolar Disord. 2008, 10:1-37.
72. Kondo H., Saleem K.S., Price J.L. Differential connections of the perirhinal and parahippocampal cortex with the orbital and medial prefrontal networks in macaque monkeys. J. Comp. Neurol. 2005, 493:479-509.
73. Koolschijn P.C., van Haren N.E., Lensvelt-Mulders G.J., Hulshoff Pol H.E., Kahn R.S. Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Hum. Brain Mapp. 2009, 30:3719-3735.
74. Kringelbach M.L. The human orbitofrontal cortex: linking reward to hedonic experience. Nat. Rev. Neurosci. 2005, 6:691-702.
75. Lacerda A.L., Keshavan M.S., Hardan A.Y., Yorbik O., Brambilla P., Sassi R.B., Nicoletti M., Mallinger A.G., Frank E., Kupfer D.J., Soares J.C. Anatomic evaluation of the orbitofrontal cortex in major depressive disorder. Biol. Psychiatry. 2004, 55:353-358.
76. Landré L., Destrieux C., Baudry M., Barantin L., Cottier J.P., Martineau J., Hommet C., Isingrini M., Belzung C., Gaillard P., Camus V., El Hage W. Preserved subcortical volumes and cortical thickness in women with sexual abuse-related PTSD. Psychiatry Res. 2010, 183:181-186.
77. Lanius R.A., Williamson P.C., Densmore M., Boksman K., Gupta M.A., Neufeld R.W., Gati J.S., Menon R.S. Neural correlates of traumatic memories in posttraumatic stress disorder: a functional MRI investigation. Am. J. Psychiatry 2001, 158:1920-1922.
78. Lansing K., Amen D.G., Hanks C., Rudy L. High-resolution brain SPECT imaging and eye movement desensitization and reprocessing in police officers with PTSD. J. Neuropsychiatry Clin. Neurosci. 2005, 17:526-532.
79. Lavretsky H., Roybal D.J., Ballmaier M., Toga A.W., Kumar A. Antidepressant exposure may protect against decrement in frontal gray matter volumes in geriatric depression. J. Clin. Psychiatry 2005, 66:964-967.
80. Lawrence A.D., Sahakian B.J., Robbins T.W. Cognitive functions and corticostriatal circuits: insights from Huntington's disease. Trends Cogn. Sci. 1998, 2:379-388.
81. Lazaro L., Bargallo N., Castro-Fornieles J., Falcon C., Andres S., Calvo R., Junque C. Brain changes in children and adolescents with obsessive-compulsive disorder before and after treatment: a voxel-based morphometric MRI study. Psychiatry Res. 2009, 172:140-146.
82. LeDoux J.E. The Emotional Brain: The Mysterious Underpinnings of Emotional Life 1998.
83. LeDoux, J.E., 2002. Synaptic Self: How our Brains become Who We are. New York, Viking Press.
84. Levin P., Lazrove S., van der Kolk B. What psychological testing and neuroimaging tell us about the treatment of posttraumatic stress disorder by eye movement desensitization and reprocessing. J. Anxiety Disord. 1999, 13:159-172.
85. Levy R., Goldman-Rakic P.S. Segregation of working memory functions within the dorsolateral prefrontal cortex. Exp. Brain Res. 2000, 133:23-32.
86. Lindauer R.J., Booij J., Habraken J.B., van Meijel E.P., Uylings H.B., Olff M., Carlier I.V., den Heeten G.J., van Eck-Smit B.L., Gersons B.P. Effects of psychotherapy on regional cerebral blood flow during trauma imagery in patients with post-traumatic stress disorder: a randomized clinical trial. Psychol. Med. 2008, 38:543-554.
87. Lindauer R.J., Vlieger E.J., Jalink M., Olff M., Carlier I.V., Majoie C.B., Den Heeten G.J., Gersons B.P. Effects of psychotherapy on hippocampal volume in out-patients with post-traumatic stress disorder: a MRI investigation. Psychol. Med. 2005, 35:1421-1431.
88. MacQueen G.M. Magnetic resonance imaging and prediction of outcome in patients with major depressive disorder. J. Psychiatry Neurosci. 2009, 34:343-349.
89. Martin S.D., Martin E., Rai S.S., Richardson M.A., Royall R. Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings. Arch. Gen. Psychiatry 2001, 58:641-648.
90. Mathew S., Price R., Shungu D., Mao X., Smith E., Amiel J., Coplan J. A pilot study of the effects of chronic paroxetine administration on hippocampal N-acetylaspartate in generalized anxiety disorder. J. Psychopharmacol. 2009, 24:1175-1181.
91. Mathew S.J., Mao X., Coplan J.D., Smith E.L., Sackeim H.A., Gorman J.M., Shungu D.C. Dorsolateral prefrontal cortical pathology in generalized anxiety disorder: a proton magnetic resonance spectroscopic imaging study. Am. J. Psychiatry 2004, 161:1119-1121.
92. Mathew S.J., Price R.B., Mao X., Smith E.L., Coplan J.D., Charney D.S., Shungu D.C. Hippocampal N-acetylaspartate concentration and response to riluzole in generalized anxiety disorder. Biol. Psychiatry 2008, 63:891-898.
93. Mayberg H.S., Brannan S.K., Tekell J.L., Silva J.A., Mahurin R.K., McGinnis S., Jerabek P.A. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol. Psychiatry 2000, 48:830-843.
94. Menzies L., Chamberlain S.R., Laird A.R., Thelen S.M., Sahakian B.J., Bullmore E.T. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci. Biobehav. Rev. 2008, 32:525-549.
95. Metcalfe J., Jacobs W.J. Emotional memory: the effects of stress on 'cool' and 'hot' memory systems. The Psychology of Learning and Motivation: Advances in Research and Theory 1998, 187-222. Academic Press, San Diego. L.M. Douglas (Ed.).
96. Milham M.P., Nugent A.C., Drevets W.C., Dickstein D.P., Leibenluft E., Ernst M., Charney D., Pine D.S. Selective reduction in amygdala volume in pediatric anxiety disorders: a voxel-based morphometry investigation. Biol. Psychiatry 2005, 57:961-966.
97. Millecamps M., Centeno M.V., Berra H.H., Rudick C.N., Lavarello S., Tkatch T., Apkarian A.V. d-Cycloserine reduces neuropathic pain behavior through limbic NMDA-mediated circuitry. Pain 2007, 132:108-123.
98. Mohanakrishnan Menon P., Nasrallah H.A., Lyons J.A., Scott M.F., Liberto V. Single-voxel proton MR spectroscopy of right versus left hippocampi in PTSD. Psychiatry Res. 2003, 123:101-108.
99. Murai R., Noda Y., Matsui K., Kamei H., Mouri A., Matsuba K., Nitta A., Furukawa H., Nabeshima T. Hypofunctional glutamatergic neurotransmission in the prefrontal cortex is involved in the emotional deficit induced by repeated treatment with phencyclidine in mice: implications for abnormalities of glutamate release and NMDA-CaMKII signaling. Behav. Brain Res. 2007, 180:152-160.
100. Myers K.M., Davis M. Mechanisms of fear extinction. Mol. Psychiatry 2007, 12:120-150.
101. Nakao T., Nakagawa A., Yoshiura T., Nakatani E., Nabeyama M., Yoshizato C., Kudoh A., Tada K., Yoshioka K., Kawamoto M., Togao O., Kanba S. Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: a functional magnetic resonance imaging study. Biol. Psychiatry 2005, 57:901-910.
102. Nakatani E., Nakgawa A., Ohara Y., Goto S., Uozumi N., Iwakiri M., Yamamoto Y., Motomura K., Iikura Y., Yamagami T. Effects of behavior therapy on regional cerebral blood flow in obsessive-compulsive disorder. Psychiatry Res. 2003, 124:113-120.
103. Nardo D., Högberg G., Looi J.C., Larsson S., Hällström T., Pagani M. Gray matter density in limbic and paralimbic cortices is associated with trauma load and EMDR outcome in PTSD patients. J. Psychiatr. Res. 2010, 44:477-485.
104. Nieuwenhuis S., Ridderinkhof K.R., Blom J., Band G.P., Kok A. Error-related brain potentials are differentially related to awareness of response errors: evidence from an antisaccade task. Psychophysiology 2001, 38:752-760.
105. Nordahl T.E., Benkelfat C., Semple W.E., Gross M., King A.C., Cohen R.M. Cerebral glucose metabolic rates in obsessive compulsive disorder. Neuropsychopharmacology 1989, 2:23-28.
106. Oh D.-H., Choi J. Changes in the regional cerebral perfusion after eye movement desensitization and reprocessing. A SPECT study of two cases. J. EMDR Practice Res. 2007, 1:24-30.
107. Ongur D., Ferry A.T., Price J.L. Architectonic subdivision of the human orbital and medial prefrontal cortex. J. Comp. Neurol. 2003, 460:425-449.
108. Onur O.A., Schlaepfer T.E., Kukolja J., Bauer A., Jeung H., Patin A., Otte D.M., Shah N.J., Maier W., Kendrick K.M., Fink G.R., Hurlemann R. The N-methyl-d-aspartate receptor co-agonist d-cycloserine facilitates declarative learning and hippocampal activity in humans. Biol. Psychiatry 2010, 67:1205-1211.
109. Pagani M., Hogberg G., Salmaso D., Nardo D., Sundin O., Jonsson C., Soares J., Aberg-Wistedt A., Jacobsson H., Larsson S.A., Hallstrom T. Effects of EMDR psychotherapy on 99mTc-HMPAO distribution in occupation-related post-traumatic stress disorder. Nucl. Med. Commun. 2007, 28:757-765.
110. Pannu Hayes J., Labar K.S., Petty C.M., McCarthy G., Morey R.A. Alterations in the neural circuitry for emotion and attention associated with posttraumatic stress symptomatology. Psychiatry Res. 2009, 172:7-15.
111. Paquette V., Levesque J., Mensour B., Leroux J.M., Beaudoin G., Bourgouin P., Beauregard M. Change the mind and you change the brain: effects of cognitive-behavioral therapy on the neural correlates of spider phobia. Neuroimage 2003, 18:401-409.
112. Pederson C.L., Maurer S.H., Kaminski P.L., Zander K.A., Peters C.M., Stokes-Crowe L.A., Osborn R.E. Hippocampal volume and memory performance in a community-based sample of women with posttraumatic stress disorder secondary to child abuse. J. Trauma. Stress 2004, 17:37-40.
113. Phan K.L., Wager T., Taylor S.F., Liberzon I. Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI. Neuroimage 2002, 16:331-348.
114. Phillips M.L., Drevets W.C., Rauch S.L., Lane R. Neurobiology of emotion perception I: the neural basis of normal emotion perception. Biol. Psychiatry 2003, 54:504-514.
115. Porto P.R., Oliveira L., Mari J., Volchan E., Figueira I., Ventura P. Does cognitive behavioral therapy change the brain? A systematic review of neuroimaging in anxiety disorders. J. Neuropsychiatry Clin. Neurosci. 2009, 21:114-125.
116. Posner M.I., DiGirolamo G.J. Executive Attention: Conflict, Target Detection, and Cognitive Control 1998, MIT Press, Cambridge, MA.
117. Prasko J., Horacek J., Zalesky R., Kopecek M., Novak T., Paskova B., Skrdlantova L., Belohlavek O., Hoschl C. The change of regional brain metabolism (18FDG PET) in panic disorder during the treatment with cognitive behavioral therapy or antidepressants. Neuro Endocrinol. Lett. 2004, 25:340-348.
118. Protopopescu X., Pan H., Tuescher O., Cloitre M., Goldstein M., Engelien W., Epstein J., Yang Y., Gorman J., LeDoux J., Silbersweig D., Stern E. Differential time courses and specificity of amygdala activity in posttraumatic stress disorder subjects and normal control subjects. Biol. Psychiatry 2005, 57:464-473.
119. Pujol J., Soriano-Mas C., Alonso P., Cardoner N., Menchon J.M., Deus J., Vallejo J. Mapping structural brain alterations in obsessive-compulsive disorder. Arch. Gen. Psychiatry 2004, 61:720-730.
120. Quirk G.J., Mueller D. Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 2008, 33:56-72.
121. Rauch S.L., Jenike M.A., Alpert N.M., Baer L., Breiter H.C., Savage C.R., Fischman A.J. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch. Gen. Psychiatry 1994, 51:62-70.
122. Rauch S.L., Shin L.M., Phelps E.A. Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research-past, present, and future. Biol. Psychiatry 2006, 60:376-382.
123. Rauch S.L., van der Kolk B.A., Fisler R.E., Alpert N.M., Orr S.P., Savage C.R., Fischman A.J., Jenike M.A., Pitman R.K. A symptom provocation study of posttraumatic stress disorder using positron emission tomography and script-driven imagery. Arch. Gen. Psychiatry 1996, 53:380-387.
124. Ressler K.J., Rothbaum B.O., Tannenbaum L., Anderson P., Graap K., Zimand E., Hodges L., Davis M. Cognitive enhancers as adjuncts to psychotherapy: use of d-cycloserine in phobic individuals to facilitate extinction of fear. Arch. Gen. Psychiatry 2004, 61:1136-1144.
125. Rigucci S., Serafini G., Pompili M., Kotzalidis G.D., Tatarelli R. Anatomical and functional correlates in major depressive disorder: the contribution of neuroimaging studies. World J. Biol. Psychiatry 2009, 1-16.
126. Rolls E.T. The orbitofrontal cortex and reward. Cereb. Cortex 2000, 10:284-294.
127. Rosenberg D.R., Benazon N.R., Gilbert A., Sullivan A., Moore G.J. Thalamic volume in pediatric obsessive-compulsive disorder patients before and after cognitive behavioral therapy. Biol. Psychiatry 2000, 48:294-300.
128. Sakai Y., Kumano H., Nishikawa M., Sakano Y., Kaiya H., Imabayashi E., Ohnishi T., Matsuda H., Yasuda A., Sato A., Diksic M., Kuboki T. Changes in cerebral glucose utilization in patients with panic disorder treated with cognitive-behavioral therapy. Neuroimage 2006, 33:218-226.
129. Saleem K.S., Kondo H., Price J.L. Complementary circuits connecting the orbital and medial prefrontal networks with the temporal, insular, and opercular cortex in the macaque monkey. J. Comp. Neurol. 2008, 506:659-693.
130. Saxena S., Gorbis E., O'Neill J., Baker S.K., Mandelkern M.A., Maidment K.M., Chang S., Salamon N., Brody A.L., Schwartz J.M., London E.D. Rapid effects of brief intensive cognitive-behavioral therapy on brain glucose metabolism in obsessive-compulsive disorder. Mol. Psychiatry 2009, 14:197-205.
131. Scarone S., Colombo C., Livian S., Abbruzzese M., Ronchi P., Locatelli M., Scotti G., Smeraldi E. Increased right caudate nucleus size in obsessive-compulsive disorder: detection with magnetic resonance imaging. Psychiatry Res. 1992, 45:115-121.
132. Schienle A., Schafer A., Hermann A., Rohrmann S., Vaitl D. Symptom provocation and reduction in patients suffering from spider phobia: an fMRI study on exposure therapy. Eur. Arch. Psychiatry Clin. Neurosci. 2007, 257:486-493.
133. Schienle A., Schafer A., Stark R., Vaitl D. Long-term effects of cognitive behavior therapy on brain activation in spider phobia. Psychiatry Res. 2009, 172:99-102.
134. Schuff N., Neylan T.C., Lenoci M.A., Du A.T., Weiss D.S., Marmar C.R., Weiner M.W. Decreased hippocampal N-acetylaspartate in the absence of atrophy in posttraumatic stress disorder. Biol. Psychiatry 2001, 50:952-959.
135. Schwartz J.M., Stoessel P.W., Baxter L.R., Martin K.M., Phelps M.E. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch. Gen. Psychiatry 1996, 53:109-113.
136. Seedat S., Warwick J., van Heerden B., Hugo C., Zungu-Dirwayi N., Van Kradenburg J., Stein D.J. Single photon emission computed tomography in posttraumatic stress disorder before and after treatment with a selective serotonin reuptake inhibitor. J. Affect. Disord. 2004, 80:45-53.
137. Shin L.M., Liberzon I. The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 2009, 35:169-191.
138. Shin L.M., Orr S.P., Carson M.A., Rauch S.L., Macklin M.L., Lasko N.B., Peters P.M., Metzger L.J., Dougherty D.D., Cannistraro P.A., Alpert N.M., Fischman A.J., Pitman R.K. Regional cerebral blood flow in the amygdala and medial prefrontal cortex during traumatic imagery in male and female Vietnam veterans with PTSD. Arch. Gen. Psychiatry 2004, 61:168-176.
139. Shin L.M., Shin P.S., Heckers S., Krangel T.S., Macklin M.L., Orr S.P., Lasko N., Segal E., Makris N., Richert K., Levering J., Schacter D.L., Alpert N.M., Fischman A.J., Pitman R.K., Rauch S.L. Hippocampal function in posttraumatic stress disorder. Hippocampus 2004, 14:292-300.
140. Smith M.E. Bilateral hippocampal volume reduction in adults with post-traumatic stress disorder: a meta-analysis of structural MRI studies. Hippocampus 2005, 15:798-807.
141. Stein M.B. Neurobiology of generalized anxiety disorder. J. Clin. Psychiatry 2009, 70(Suppl. 2):15-19.
142. Stickgold R. EMDR: a putative neurobiological mechanism of action. J. Clin. Psychol. 2002, 58:61-75.
143. Stone E.A., Lin Y., Quartermain D. A final common pathway for depression? Progress toward a general conceptual framework. Neurosci. Biobehav. Rev. 2008, 32:508-524.
144. Straube T., Glauer M., Dilger S., Mentzel H.J., Miltner W.H. Effects of cognitive-behavioral therapy on brain activation in specific phobia. Neuroimage 2006, 29:125-135.
145. Straube T., Mentzel H.J., Miltner W.H. Waiting for spiders: brain activation during anticipatory anxiety in spider phobics. Neuroimage 2007, 37:1427-1436.
146. Szeszko P.R., MacMillan S., McMeniman M., Chen S., Baribault K., Lim K.O., Ivey J., Rose M., Banerjee S.P., Bhandari R., Moore G.J., Rosenberg D.R. Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive-compulsive disorder. Am J Psychiatry 2004, 161:1049-1056.
147. Szeszko P.R., MacMillan S., McMeniman M., Lorch E., Madden R., Ivey J., Banerjee S.P., Moore G.J., Rosenberg D.R. Amygdala volume reductions in pediatric patients with obsessive-compulsive disorder treated with paroxetine: preliminary findings. Neuropsychopharmacology 2004, 29:826-832.
148. Valente A.A., Miguel E.C., Castro C.C., Amaro E., Duran F.L., Buchpiguel C.A., Chitnis X., McGuire P.K., Busatto G.F. Regional gray matter abnormalities in obsessive-compulsive disorder: a voxel-based morphometry study. Biol. Psychiatry 2005, 58:479-487.
149. van den Hout M.A., Engelhard I.M., Rijkeboer M.M., Koekebakker J., Hornsveld H., Leer A., Toffolo M.B., Akse N. EMDR: eye movements superior to beeps in taxing working memory and reducing vividness of recollections. Behav. Res. Ther. 2011, 49:92-98.
150. Van Der Kolk B.A., Burbridge J.A., Suzuki J. The psychobiology of traumatic memory. Clinical implications of neuroimaging studies. Ann. N. Y. Acad. Sci. 1997, 821:99-113.
151. Van der Linden G., van Heerden B., Warwick J., Wessels C., van Kradenburg J., Zungu-Dirwayi N., Stein D.J. Functional brain imaging and pharmacotherapy in social phobia: single photon emission computed tomography before and after treatment with the selective serotonin reuptake inhibitor citalopram. Prog. Neuropsychopharmacol. Biol. Psychiatry 2000, 24:419-438.
152. van Tol M.J., van der Wee N.J., van den Heuvel O.A., Nielen M.M., Demenescu L.R., Aleman A., Renken R., van Buchem M.A., Zitman F.G., Veltman D.J. Regional brain volume in depression and anxiety disorders. Arch. Gen. Psychiatry 2010, 67:1002-1011.
153. Veltman D.J., Tuinebreijer W.E., Winkelman D., Lammertsma A.A., Witter M.P., Dolan R.J., Emmelkamp P.M. Neurophysiological correlates of habituation during exposure in spider phobia. Psychiatry Res. 2004, 132:149-158.
154. Vermetten E., Vythilingam M., Southwick S.M., Charney D.S., Bremner J.D. Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder. Biol. Psychiatry 2003, 54:693-702.
155. Vlassenko A., Sheline Y.I., Fischer K., Mintun M.A. Cerebral perfusion response to successful treatment of depression with different serotoninergic agents. J. Neuropsychiatry Clin. Neurosci. 2004, 16:360-363.
156. Vythilingam M., Vermetten E., Anderson G.M., Luckenbaugh D., Anderson E.R., Snow J., Staib L.H., Charney D.S., Bremner J.D. Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biol. Psychiatry 2004, 56:101-112.
157. Warwick J.M., Carey P., Van der Linden G., Prinsloo C., Niehaus D., Seedat S., Dupont P., Stein D.J. A comparison of the effects of citalopram and moclobemide on resting brain perfusion in social anxiety disorder. Metab. Brain Dis. 2006, 21:241-252.
158. Weiss S.J. Neurobiological alterations associated with traumatic stress. Perspect. Psychiatr. Care 2007, 43:114-122.
159. Wendt J., Lotze M., Weike A.I., Hosten N., Hamm A.O. Brain activation and defensive response mobilization during sustained exposure to phobia-related and other affective pictures in spider phobia. Psychophysiology 2008, 45:205-215.
160. Whiteside S.P., Port J.D., Abramowitz J.S. A meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Res. 2004, 132:69-79.
161. Woodward S.H., Kaloupek D.G., Streeter C.C., Martinez C., Schaer M., Eliez S. Decreased anterior cingulate volume in combat-related PTSD. Biol. Psychiatry 2006, 59:582-587.
162. Woon F.L., Hedges D.W. Hippocampal and amygdala volumes in children and adults with childhood maltreatment-related posttraumatic stress disorder: a meta-analysis. Hippocampus 2008, 18:729-736.
163. Yamanishi T., Nakaaki S., Omori I.M., Hashimoto N., Shinagawa Y., Hongo J., Horikoshi M., Tohyama J., Akechi T., Soma T., Iidaka T., Furukawa T.A. Changes after behavior therapy among responsive and nonresponsive patients with obsessive-compulsive disorder. Psychiatry Res. 2009, 172:242-250.
164. Yamasaki H., LaBar K.S., McCarthy G. Dissociable prefrontal brain systems for attention and emotion. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:11447-11451.
165. Yehuda R., Golier J.A., Tischler L., Harvey P.D., Newmark R., Yang R.K., Buchsbaum M.S. Hippocampal volume in aging combat veterans with and without post-traumatic stress disorder: relation to risk and resilience factors. J. Psychiatr. Res. 2007, 41:435-445.